123 related articles for article (PubMed ID: 26341888)
1. The inconveniences of active surveillance in prostate cancer.
Sánchez-de-Badajoz E
Actas Urol Esp; 2016 Mar; 40(2):69-71. PubMed ID: 26341888
[No Abstract] [Full Text] [Related]
2. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
Loeb S; Berglund A; Stattin P
J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
[TBL] [Abstract][Full Text] [Related]
3. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer.
Haffty BG; Lawton CA; Sandler H
JAMA Oncol; 2015 Aug; 1(5):688-9. PubMed ID: 26182350
[No Abstract] [Full Text] [Related]
4. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply.
Williams SB; Chamie K; Hu JC
JAMA Oncol; 2015 Aug; 1(5):689-90. PubMed ID: 26181144
[No Abstract] [Full Text] [Related]
5. [Editorial. Monographic: Active surveillance in prostate cancer].
Rubio-Briones J; Narbón ES
Arch Esp Urol; 2014 Jun; 67(5):369-71. PubMed ID: 25039088
[No Abstract] [Full Text] [Related]
6. What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer?
Dall'Era M; Carroll P
J Urol; 2015 Sep; 194(3):615-6. PubMed ID: 26079332
[No Abstract] [Full Text] [Related]
7. Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.
J Natl Compr Canc Netw; 2011 May; 9(5):xxxvii-xlii. PubMed ID: 21739727
[No Abstract] [Full Text] [Related]
8. [Active surveillance in prostate cancer. Introduction].
Briones JR
Arch Esp Urol; 2014 Jun; 67(5):367-8. PubMed ID: 25039087
[No Abstract] [Full Text] [Related]
9. Active surveillance for prostate cancer: barriers to widespread adoption.
Sandhu GS; Andriole GL
Eur Urol; 2012 Dec; 62(6):984-5. PubMed ID: 22770662
[No Abstract] [Full Text] [Related]
10. Significance of Change in Gleason Grade in Patients on Active Surveillance for Prostate Cancer.
Marks LS
J Urol; 2015 Jul; 194(1):8-9. PubMed ID: 25892137
[No Abstract] [Full Text] [Related]
11. The expanding role of body mass in active surveillance for prostate cancer.
Ahearn TU; Shui IM; Giovannucci EL
Eur Urol; 2014 Nov; 66(5):849-50. PubMed ID: 25037639
[No Abstract] [Full Text] [Related]
12. Words of wisdom. Re: Medium-term outcomes of active surveillance for localized prostate cancer.
Mir MC; Stephenson AJ
Eur Urol; 2013 Dec; 64(6):1013-4. PubMed ID: 24209447
[No Abstract] [Full Text] [Related]
13. [Economic features of active surveillance].
Huguet J; Musquera M; Ribal MJ; Alcaraz A
Arch Esp Urol; 2014 Jun; 67(5):509-13. PubMed ID: 24914850
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance for early-stage prostate cancer.
Lancet; 2014 Jan; 383(9913):188. PubMed ID: 24439724
[No Abstract] [Full Text] [Related]
15. Active surveillance preferred for low-risk prostate cancer.
Bagcchi S
Lancet Oncol; 2015 Aug; 16(8):e384. PubMed ID: 26190749
[No Abstract] [Full Text] [Related]
16. [Watchful waiting in incidental adenocarcinoma of the prostate].
Morán Pascual E; Dicapua Sacoto C; Trassierra Villa M; Pontones Moreno JL; Ruiz Cerdá JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Nov; 34(10):854-9. PubMed ID: 21159280
[TBL] [Abstract][Full Text] [Related]
17. Predictive significance of confirmation biopsies in patients on active surveillance.
Wirth MP; Froehner M
Eur Urol; 2014 Sep; 66(3):414-5. PubMed ID: 23746853
[No Abstract] [Full Text] [Related]
18. Words of wisdom. Re: Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.
Klaassen Z; Wyatt B; Moses KA; Terris MK
Eur Urol; 2013 Nov; 64(5):855. PubMed ID: 24112612
[No Abstract] [Full Text] [Related]
19. Active surveillance helps prostate cancer patients keep quality of life, findings show.
Printz C
Cancer; 2017 Aug; 123(16):2997. PubMed ID: 28777452
[No Abstract] [Full Text] [Related]
20. [Prostatectomy vs. "watchful waiting" in early prostate cancer].
Markun S
Praxis (Bern 1994); 2014 Jul; 103(15):909-10. PubMed ID: 25051936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
